SAINBIOSE is major research center in translational and basic biomedical research endorsed by Inserm (U1059), the Jean Monnet University of Saint-Etienne and the Mines Saint-Etienne School of Engineering. It was founded in 2016, stemming from the pionner initiative of Saint-Etienne universities in the years 2000’s to bring together Engineering and Health Sciences together within a University Hospital campus (current campus santé where SAINBIOSE is located).

SAINBIOSE gathers together 8 research groups (150 staff) organized in 2 teams: the DVH team working on hemostasis and vascular dysfunctions, and the LBTO team working on osteoarticular physiopathology and engineering.

The common goal shared by all SAINBIOSE is to develop multiscale models (in silico and in vitro) for better understanding and adressing the interactions between inflammation and mechanobiology in cardiovascular and osteoarticular diseases. To achieve this, SAINBIOSE develops a scientific strategy based on a unique combination of scientific expertise spanning molecular and cellular biology, biomechanics and biomaterials, pharmacology and clinical translation. This approach generates both fundamental and translational advances applied to the global challenge of improving health and well-being for ALL.